Economic Impact of Heart Failure According to the Effects of Kidney Failure

Antoni Sicras Mainar; Ruth Navarro Artieda; Jordi Ibáñez Nolla

doi:10.1016/j.recesp.2014.02.023

Economic Impact of Heart Failure According to the Effects of Kidney Failure

Título traducido de la contribución: Impacto económico de la insuficiencia cardiaca según la influencia de la insuficiencia renal

Antoni Sicras Mainar^*
, Ruth Navarro Artieda
, Jordi Ibáñez Nolla

^*Autor/a de correspondencia de este trabajo

Producción científica: Artículo en revista indizada › Artículo › revisión exhaustiva

22 Citas (Scopus)

Resumen

Introducción y objetivos
Evaluar el uso de los recursos sanitarios y sus costes según la influencia de la insuficiencia renal en sujetos con insuficiencia cardiaca durante un periodo de seguimiento de 2 años en un ámbito poblacional.
Métodos
Se efectuó un diseño observacional-retrospectivo realizado a partir de la revisión de registros médicos. Se incluyó a sujetos ≥ 45 años que demandaron atención durante 2008-2010. Se constituyeron dos grupos según los pacientes tuvieran insuficiencia renal o no. Principales mediciones: comorbilidad, clínicas (clase funcional, etiología), síndrome metabólico, costes y nuevos casos de eventos cardiovasculares e insuficiencia renal. El modelo de costes incluyó los costes sanitarios directos e indirectos. El análisis estadístico incluyó modelos de regresión múltiple.
Resultados
Se reclutó a 1.600 sujetos (prevalencia, 4,0%; media de edad, 72,4 años; mujeres, 59,7%). El 70,1% tenía hipertensión; el 47,1%, dislipemia y el 36,2%, diabetes mellitus. Se analizó a 433 pacientes (27,1%) con insuficiencia renal y a 1.167 (72,9%) sin ella. Los pacientes con insuficiencia renal se asociaron a la clase funcional III-IV (el 54,1 frente al 40,8%) y síndrome metabólico (el 65,3 frente al 51,9%; p < 0,01). El promedio unitario del coste fue 10.711,4 euros. El coste corregido en presencia de insuficiencia renal fue 14.868,2 frente a 9.364,5 euros (p = 0,001). Durante el seguimiento, el 11,7% sufrió cardiopatía isquémica; el 18,8%, insuficiencia renal y el 36,1%, reagudización de la insuficiencia cardiaca.
Conclusiones
La comorbilidad asociada a la insuficiencia cardiaca es elevada. La presencia de insuficiencia renal ocasiona más utilización de recursos sanitarios y mayores costes para el Sistema Nacional de Salud.

Título traducido de la contribución	Impacto económico de la insuficiencia cardiaca según la influencia de la insuficiencia renal
Idioma original	Inglés
Páginas (desde-hasta)	39-46
Número de páginas	8
Publicación	Revista Espanola de Cardiologia
Volumen	68
N.º	1
DOI	https://doi.org/10.1016/j.recesp.2014.02.023
Estado	Publicada - 1 ene 2015
Publicado de forma externa	Sí

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

ODS 3: Salud y bienestar

Palabras clave

Direct costs
Heart failure
Indirect costs
Kidney failure
Use of resources

Acceder al documento

10.1016/j.recesp.2014.02.023

Otros archivos y enlaces

Enlace a la publicación en Scopus

Cómo citar

@article{bcba533fedfc43dd8a5c22ef7b2174cf,

title = "Economic Impact of Heart Failure According to the Effects of Kidney Failure",

abstract = "Introduction and objectives To evaluate the use of health care resources and their cost according to the effects of kidney failure in heart failure patients during 2-year follow-up in a population setting. Methods Observational retrospective study based on a review of medical records. The study included patients ≥ 45 years treated for heart failure from 2008 to 2010. The patients were divided into 2 groups according to the presence/absence of kidney failure. Main outcome variables were comorbidity, clinical status (functional class, etiology), metabolic syndrome, costs, and new cases of cardiovascular events and kidney failure. The cost model included direct and indirect health care costs. Statistical analysis included multiple regression models. Results The study recruited 1600 patients (prevalence, 4.0\%; mean age 72.4 years; women, 59.7\%). Of these patients, 70.1\% had hypertension, 47.1\% had dyslipidemia, and 36.2\% had diabetes mellitus. We analyzed 433 patients (27.1\%) with kidney failure and 1167 (72.9\%) without kidney failure. Patients with kidney failure were associated with functional class III-IV (54.1\% vs 40.8\%) and metabolic syndrome (65.3\% vs 51.9\%, P <.01). The average unit cost was €10 711.40. The corrected cost in the presence of kidney failure was €14 868.20 vs €9364.50 (P =.001). During follow-up, 11.7\% patients developed ischemic heart disease, 18.8\% developed kidney failure, and 36.1\% developed heart failure exacerbation. Conclusions Comorbidity associated with heart failure is high. The presence of kidney failure increases the use of health resources and leads to higher costs within the National Health System.",

keywords = "Direct costs, Heart failure, Indirect costs, Kidney failure, Use of resources",

author = "\{Sicras Mainar\}, Antoni and \{Navarro Artieda\}, Ruth and \{Ib{\'a}{\~n}ez Nolla\}, Jordi",

note = "Publisher Copyright: {\textcopyright} 2014 Sociedad Espa{\~n}ola de Cardiolog{\'i}a. Publicado por Elsevier Espa{\~n}a, S.L.U.",

year = "2015",

month = jan,

day = "1",

doi = "10.1016/j.recesp.2014.02.023",

language = "English",

volume = "68",

pages = "39--46",

journal = "Revista Espanola de Cardiologia",

issn = "0300-8932",

publisher = "Ediciones Doyma, S.L.",

number = "1",

}

TY - JOUR

T1 - Economic Impact of Heart Failure According to the Effects of Kidney Failure

AU - Sicras Mainar, Antoni

AU - Navarro Artieda, Ruth

AU - Ibáñez Nolla, Jordi

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Introduction and objectives To evaluate the use of health care resources and their cost according to the effects of kidney failure in heart failure patients during 2-year follow-up in a population setting. Methods Observational retrospective study based on a review of medical records. The study included patients ≥ 45 years treated for heart failure from 2008 to 2010. The patients were divided into 2 groups according to the presence/absence of kidney failure. Main outcome variables were comorbidity, clinical status (functional class, etiology), metabolic syndrome, costs, and new cases of cardiovascular events and kidney failure. The cost model included direct and indirect health care costs. Statistical analysis included multiple regression models. Results The study recruited 1600 patients (prevalence, 4.0%; mean age 72.4 years; women, 59.7%). Of these patients, 70.1% had hypertension, 47.1% had dyslipidemia, and 36.2% had diabetes mellitus. We analyzed 433 patients (27.1%) with kidney failure and 1167 (72.9%) without kidney failure. Patients with kidney failure were associated with functional class III-IV (54.1% vs 40.8%) and metabolic syndrome (65.3% vs 51.9%, P <.01). The average unit cost was €10 711.40. The corrected cost in the presence of kidney failure was €14 868.20 vs €9364.50 (P =.001). During follow-up, 11.7% patients developed ischemic heart disease, 18.8% developed kidney failure, and 36.1% developed heart failure exacerbation. Conclusions Comorbidity associated with heart failure is high. The presence of kidney failure increases the use of health resources and leads to higher costs within the National Health System.

AB - Introduction and objectives To evaluate the use of health care resources and their cost according to the effects of kidney failure in heart failure patients during 2-year follow-up in a population setting. Methods Observational retrospective study based on a review of medical records. The study included patients ≥ 45 years treated for heart failure from 2008 to 2010. The patients were divided into 2 groups according to the presence/absence of kidney failure. Main outcome variables were comorbidity, clinical status (functional class, etiology), metabolic syndrome, costs, and new cases of cardiovascular events and kidney failure. The cost model included direct and indirect health care costs. Statistical analysis included multiple regression models. Results The study recruited 1600 patients (prevalence, 4.0%; mean age 72.4 years; women, 59.7%). Of these patients, 70.1% had hypertension, 47.1% had dyslipidemia, and 36.2% had diabetes mellitus. We analyzed 433 patients (27.1%) with kidney failure and 1167 (72.9%) without kidney failure. Patients with kidney failure were associated with functional class III-IV (54.1% vs 40.8%) and metabolic syndrome (65.3% vs 51.9%, P <.01). The average unit cost was €10 711.40. The corrected cost in the presence of kidney failure was €14 868.20 vs €9364.50 (P =.001). During follow-up, 11.7% patients developed ischemic heart disease, 18.8% developed kidney failure, and 36.1% developed heart failure exacerbation. Conclusions Comorbidity associated with heart failure is high. The presence of kidney failure increases the use of health resources and leads to higher costs within the National Health System.

KW - Direct costs

KW - Heart failure

KW - Indirect costs

KW - Kidney failure

KW - Use of resources

UR - https://www.scopus.com/pages/publications/84920748420

U2 - 10.1016/j.recesp.2014.02.023

DO - 10.1016/j.recesp.2014.02.023

M3 - Article

C2 - 25553938

AN - SCOPUS:84920748420

SN - 0300-8932

VL - 68

SP - 39

EP - 46

JO - Revista Espanola de Cardiologia

JF - Revista Espanola de Cardiologia

IS - 1

ER -

Economic Impact of Heart Failure According to the Effects of Kidney Failure

Resumen

ODS de las Naciones Unidas

Palabras clave

Acceder al documento

Otros archivos y enlaces

Huella

Cómo citar